Depression Studies

Marked by sadness, reduced activity, difficulty concentrating, and feelings of dejection or hopelessness, depression can seriously impact quality of life. Due to the severity of these symptoms, and relatively few options available for treatment, new antidepressant therapies remain an area of critical need.

Partner with our scientists to run your studies in well-characterized, disease-relevant models, and command an unmatched toolkit of imaging capabilities, behavioral assays and biomarkers.

Take a Virtual Tour

Our research facility is outfitted to handle a high volume of neurology and psychiatry preclinical drug discovery studies. Watch the video »

You may also be interested in...

Biomarker Services

We can support your drug discovery pipeline by providing biomarker analysis in a non-GxP environment.